Cardiovascular Revascularization Medicine
Volume 10, Issue 2 , Pages 110-116, April 2009

Effects of exogenous peripheral-blood-derived endothelial progenitor cells or unfractionated bone-marrow-derived cells on neointimal formation and inflammation in cholesterol-fed, balloon-denuded, and radiated iliac arteries of inbred rabbits

  • Ron Waksman

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC, USA
    • Corresponding Author InformationCorresponding author. Washington Hospital Center, 110 Irving Street, NW, Suite 4B-1, Washington, DC 20010, USA.
  • ,
  • Richard Baffour

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC, USA
  • ,
  • Rajbabu Pakala

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC, USA
  • ,
  • Mickey Scheinowitz

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC, USA
  • ,
  • David Hellinga

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC, USA
  • ,
  • Rufus Seabron

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC, USA
  • ,
  • Rosanna Chan

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC, USA
  • ,
  • Frank Kolodgie

      Affiliations

    • CV Path, International Registry of Pathology, Gaithersburg, MD, USA
  • ,
  • Renu Virmani

      Affiliations

    • CV Path, International Registry of Pathology, Gaithersburg, MD, USA

Received 3 February 2009; accepted 3 February 2009.

Abstract 

Background

Injection of bone marrow cells (BMC) and endothelial progenitor cells (EPC) or application of stem-cell-mobilizing factors has been associated both with reduction or exacerbation of atherosclerosis and with unstable plaque phenotype. The discrepancies may reflect the cell type, dosing, duration, and route of administration of cells in these studies. The aim of this study was to determine the effects of peripheral-blood-derived endothelial progenitor cells (PBEPC) or unfractionated BMC obtained from inbred siblings on neointimal formation and inflammation in cholesterol-fed, balloon-denuded, and radiated rabbit iliac arteries.

Methods

Rabbits were fed a 1.0% cholesterol diet for 14 days, followed by endothelial denudation in both iliac arteries, and continued on a 0.15% cholesterol diet. On day 42, denuded areas were radiated, and animals were randomized. The first group received PBEPC (n=5), the second group received BMC (n=4), and the third group received heparinized (20 IU) saline (Control; n=3). PBEPC were characterized by flow cytometry. Cells (5×106) or saline was administered twice through the ear vein: the first time at 1 h after radiation and the second time at 2 weeks after radiation. Four weeks after radiation, the animals were sacrificed, and arterial segments were processed for morphometry.

Results

Administration of BMC or PBEPC from inbred siblings had no adverse effect. Lumen area (0.93±0.53 mm2), neointimal area (0.65±0.29 mm2), percent stenosis (44±21), and macrophage score (0.6±0.3) in controls were similar to those in cell-treated groups.

Conclusion

This study demonstrates that, in the current animal model, either PBEPC or BMC failed to affect neointimal formation or inflammation.

Keywords: Endothelial progenitor cells, Bone marrow, Peripheral blood endothelial progenitor cells, Restenosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1553-8389(09)00044-X

doi:10.1016/j.carrev.2009.02.001

Cardiovascular Revascularization Medicine
Volume 10, Issue 2 , Pages 110-116, April 2009